Jessica Gordon - Concepedia

Author

Jessica Gordon

Also Known As

Anna Gill, Anne Gerber, Dominique Farge-Bancel, Gordon, Jessica, Gordon, Jessica K., J Gordon, J. Gordon, J. K. Gordon, J. KEITH GORDON, J.K. Gordon

157

Publications

Citations

H-Index

107

Concepts

All Affiliations

Hospital for Special Surgery Georgetown University University of Michigan University of Utah Johns Hopkins University

About

Jessica Gordon is an author at Hospital for Special Surgery specializing in medicine, scleroderma, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	852
2	Public Health	6	6	265
3	Allergy	3	3	83
4	Health Sciences	2	2	69
5	Biostatistics	1	1	68

Jessica Gordon

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients Lisa Rice, Cristina M. Padilla, Sarah McLaughlin, Journal of Clinical Investigation	2015	334
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8 Marie Dominique Ah Kioon, Claudio Tripodo, David Fernández, Science Translational Medicine	2018	233
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase <scp>II</scp> Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Trial Dinesh Khanna, Cathie Spino, Sindhu R. Johnson, Arthritis & Rheumatology	2019	218
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial Robert Spiera, Jessica Gordon, Jamie Mersten, Annals of the Rheumatic Diseases	2011	173
Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry Robyn T. Domsic, Bharathi Lingala, Firas Alkassab, Arthritis Care & Research	2013	168
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile Brian Skaug, Dinesh Khanna, William R. Swindell, Annals of the Rheumatic Diseases	2019	167
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Jessica Gordon, Viktor Martyanov, Jennifer M. Franks, Arthritis & Rheumatology	2017	125
Clinical and serological features of systemic sclerosis in a multicenter African American cohort Nadia D. Morgan, Ami A. Shah, Maureen D. Mayes, Medicine	2017	113
A Longitudinal Biomarker for the Extent of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis Lisa Rice, Jessica Ziemek, Eric A. Stratton, Arthritis & Rheumatology	2015	111
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis Robert Spiera, Laura K. Hummers, Tracy Frech, Arthritis & Rheumatology	2020	101

Page 1